Lapatinib-Capecitabine Versus Capecitabine Alone as Radiosensitizers in Ras Wild-Type Resectable Rectal Cancer, an Adaptive Randomized Phase Ii Trial (Larrc Trial): Study Protocol for a Randomized Controlled Trial

AuthID
P-00K-X85
Tipo de Documento
Article
Year published
2016
Publicado
in TRIALS, ISSN: 1745-6215
Volume: 17, Número: 1
Indexing
Publication Identifiers
SCOPUS: 2-s2.0-84988535628
Wos: WOS:000383658300001
Source Identifiers
ISSN: 1745-6215
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.